Sanofi To Divest 60% Of Brands In Consumer Healthcare Overhaul
Executive Summary
Sanofi will look to offload around 150 OTC brands as part of a radical overhaul of its Consumer Healthcare operation. The new head of the business Julie Van Ongevalle has unveiled a wide-ranging turnaround plan with the goal of transforming Sanofi into the OTC market leader.
You may also be interested in...
Sanofi Takes The Plunge With Consumer Health Separation After Years Laying Groundwork
Sanofi's participation in the OTC market could end as early as next year with its plan to completely separate from its Consumer Healthcare business.
Stada Strikes Deal With Sanofi For Well-Established European Brands
Stada will strengthen its Consumer Healthcare business in key markets like Germany and the UK with the acquisition from Sanofi of an OTC brand portfolio including Opticrom eye drops and Omnivit vitamins.
Stada Strikes Deal With Sanofi For Well-Established European Brands
Stada will strengthen its Consumer Healthcare business in key markets like Germany and the UK with the acquisition from Sanofi of an OTC brand portfolio including Opticrom eye drops and Omnivit vitamins.